These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3057638)

  • 21. An integrated view of the activities of defibrotide.
    Pescador R; Porta R; Ferro L
    Semin Thromb Hemost; 1996; 22 Suppl 1():71-5. PubMed ID: 8807733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The fibrinolytic mechanism of defibrotide: effect of defibrotide on plasmin activity.
    Echart CL; Graziadio B; Somaini S; Ferro LI; Richardson PG; Fareed J; Iacobelli M
    Blood Coagul Fibrinolysis; 2009 Dec; 20(8):627-34. PubMed ID: 19809307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Defibrotide blunts the prothrombotic effect of thalidomide on endothelial cells.
    Echart CL; Somaini S; Distaso M; Palumbo A; Richardson PG; Fareed J; Iacobelli M
    Clin Appl Thromb Hemost; 2012; 18(1):79-86. PubMed ID: 21733935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of defibrotide in the treatment of acute myocardial infarction.
    Milazzotto F; Carelli M; Citone C; Di Marcotullio G; Giampaolo P; Malinconico U; Polizzi C; Tubaro M; Giovannini E; Boccardi L
    Semin Thromb Hemost; 1989 Oct; 15(4):464-9. PubMed ID: 2814516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Defibrotide and peripheral obliterative arterial disease: preliminary data.
    Arosio E; Pancera P; Zannoni M; Arcaro G; Priante F; Lechi A
    Int J Clin Pharmacol Ther Toxicol; 1989 Nov; 27(11):526-9. PubMed ID: 2533180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of defibrotide in immunoregulation of sheep red cell sensitization in a rat model.
    Silberman S; Fareed J; Cornelli U
    Semin Thromb Hemost; 1988; 14 Suppl():43-6. PubMed ID: 3057636
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of defibrotide on polymorphonuclear leukocytes: modulation of calcium entry and availability.
    Di Perri T; Pasini FL
    Semin Thromb Hemost; 1988; 14 Suppl():23-6. PubMed ID: 2848322
    [No Abstract]   [Full Text] [Related]  

  • 28. Prolonged survival of grafted rat hearts by use of defibrotide and cyclosporine.
    Corsi M; Marni A; Gaja G; Ferrero ME
    Transplant Proc; 1993 Dec; 25(6):3281-2. PubMed ID: 8266543
    [No Abstract]   [Full Text] [Related]  

  • 29. Defibrotide reduces monocyte PAI-2 and procoagulant activity.
    Abbate R; Gori AM; Martini F; Attanasio M; Comeglio P; Giusti B; Zarone N; Francalanci I; Prisco D; Gensini GF
    Semin Thromb Hemost; 1995; 21(2):245-50. PubMed ID: 7660147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defibrotide for hepatic VOD in children: exact statistics can help!
    Ammann RA
    Bone Marrow Transplant; 2004 Aug; 34(3):277-8. PubMed ID: 15170162
    [No Abstract]   [Full Text] [Related]  

  • 31. [Use of defibrotide in the treatment of acute superficial thrombophlebitis of the legs].
    Seccia M; Bortolotti P; Bellomini MG; Buccianti P; Chiarugi M; Cavina E
    Minerva Chir; 1989 May; 44(9):1379-84. PubMed ID: 2761740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of defibrotide treatment in favoring the function of the grafted heart and kidney in rats.
    Ferrero ME; Corsi M; Marni A; Gaja G
    Transplant Proc; 1994 Feb; 26(1):251-2. PubMed ID: 8108964
    [No Abstract]   [Full Text] [Related]  

  • 33. Improved grafted rat heart metabolic function using defibrotide.
    Ferrero ME; Marni A; Corsi M; Gaja G
    Transplant Proc; 1993 Dec; 25(6):3222-4. PubMed ID: 8266522
    [No Abstract]   [Full Text] [Related]  

  • 34. Protection from myocardial ischemic injury in cats and pigs by defibrotide--different mode of action?
    Hohlfeld T; Thiemermann C; Schrör K
    Prog Clin Biol Res; 1989; 301():137-41. PubMed ID: 2508097
    [No Abstract]   [Full Text] [Related]  

  • 35. Thrombolytic activity of defibrotide: a morphometric evaluation in experimental venous thrombosis.
    Fumagalli G; Sala C; Angelaccio E; Lombardo N; Clementi F
    Pharmacol Res; 1989; 21(3):293-8. PubMed ID: 2748512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of deep venous thrombosis in orthopedic surgery: effects of defibrotide.
    Zanasi R; Fioretta G; Ciocia G; Bergonzi M
    Clin Ther; 1988; 10(4):350-7. PubMed ID: 3079005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in platelet reactivity, prostacyclin and thromboxane production after long-term oral defibrotide in healthy and atherosclerotic rabbits.
    Löbel P; Palmér M; Schrör K
    Prog Clin Biol Res; 1987; 242():265-70. PubMed ID: 3313414
    [No Abstract]   [Full Text] [Related]  

  • 38. Defibrotide in vitro inhibits neutrophil activation by a Ca++-involving mechanism.
    Di Perri T; Laghi Pasini F; Capecchi PL; Ceccatelli L; Pasqui AL; Orrico A
    Int J Tissue React; 1987; 9(5):399-406. PubMed ID: 3667109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute t-PA release by defibrotide.
    Klöcking HP
    Thromb Res; 1992 Jun; 66(6):779-85. PubMed ID: 1519236
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of acute myocardial infarction with defibrotide.
    Mattioli G; Cappello C; Fusaro MT
    Semin Thromb Hemost; 1989 Oct; 15(4):470-3. PubMed ID: 2814517
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.